Development of Typology-based Smoking Relapse Prevention: A Q-methodology and a Pilot Randomized Controlled Trial - Trial NCT06261385
Access comprehensive clinical trial information for NCT06261385 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 510 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Hong Kong
Timeline & Enrollment
N/A
Jan 23, 2024
Jan 31, 2025
Primary Outcome
self-reported abstinence in the past 30 days at 2-month follow-up,iScreen OFD Cotinine Saliva Test Kit (30ng/ml) biochemical validated tobacco abstinence,the difference of the feasibility and acceptability score of the typology-based intervention between the intervention and control group.
Summary
This study aims to develop a typology-based intervention delivered by smoking cessation (SC)
 counselors to prevent smoking relapse in ex-smokers who recently quit. The two main research
 questions include (1) Can a typology-based smoking relapse prevention intervention be
 feasible and accepted by the smokers and SC counselors who deliver the new intervention? (2)
 What is the preliminary evidence on the efficacy of the typology-based smoking relapse
 prevention to increase tobacco abstinence in ex-smokers who have recently quit? If the
 intervention shows at least a small effect size (i.e. risk ratio1.3), or the intervention is
 feasible while modifications can potentially increase the efficacy, a future definitive RCT
 is warranted.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06261385
Non-Device Trial